{"disease":{"id":"hpv-human-papillomavirus-associated-carcinoma","name":"hpv human papillomavirus associated carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06686043","title":"HPV Vaccine, Imiquimod, and Metformin Combination Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT07209189","title":"Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT01958515","title":"Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}